Clinical trial · Interventional
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma
NCT04424472CI-TRIAL-00046885unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultrasonography | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ultrasonography
- description
- Patient will be scheduled to undergo an additional US by a blinded sonographer within 4 weeks of their most recent cross-sectional imaging that indicated a recurrence
- interventionNames
- Diagnostic Test: Ultrasonography
Primary outcomes (1)
- measure
- Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences
- timeFrame
- 4 weeks
- description
- Renal Cell Carcinoma (RCC) recurrence detection of ultrasonography in patients who have undergo definitive therapy for RCC compared to detection rate of cross-sectional imaging
Secondary outcomes (1)
- measure
- Radiation Burden
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients must be 18 year of age or older. * Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma. * Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI). Exclusion Criteria: * Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland). * Patients with metastatic disease prior to time of surgery requiring systemic treatment. * Patients with another active cancer diagnosis requiring systemic treatment. * Patients with contrast allergies. * Patients with baseline chronic kidney disease (GFR \< 45 ml/min/1.73 m2).
References
Publications (0)
Data not yet available
No reference posted for this study.